JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(2):55-59

Pharmaceutical Hydrophilic Gels

Z. Chalupová1, R. Masteiková1, A. Savickas2
1 Veterinární a farmaceutická fakulta Brno, Farmaceutická fakulta, Ústav technologie léků
2 Farmaceutická fakulta Kaunasské univerzity medicíny, Kaunas, Litva, Katedra technologie léků a OEF

From the pharmacopoeial standpoint, gels, together with ointments, creams, pastes, cataplasmata, and medicated plasters, rank among the group of topical semisolid preparations applied to the skin. They are bicoherent systems composed of the internal phase made of a polymer producing a coherent three-dimensional net-like structure, which fixes the liquid vehicle as the external phase. Intermolecular forces bind the molecules of the solvent to a polymeric net, thus decreasing the mobility of these molecules and producing a structured system with increased viscosity. The physical and chemical bonds binding the particles of the internal phase provide a relatively stable structure, which can originate by swelling of solid polymers, or by decreasing the solubility of the polymer in a solution. An important group of gels used in pharmacy are hydrophylic gels, or hydrogels, usually made of hydrophyilc polymers, which under certain conditions and polymer concentration, jellify. Attention of pharmaceutical research now concentrates primarily on hydrophilic gels, as this dosage form seems to be prospective for the development of modern drugs based on systems with prolonged and controlled release of active ingredients.

Keywords: hydrogels; net-like structures; drug transport systems; controlled release

Received: June 7, 2004; Accepted: July 23, 2004; Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chalupová Z, Masteiková R, Savickas A. Pharmaceutical Hydrophilic Gels. Čes. slov. farm. 2005;54(2):55-59.
Download citation

References

  1. Ščukin, E. D., Percov, A. V., Amelinova, E. A.: Koloidní chemie. 1. vyd. Praha, Academia, 1990, 484 s.
  2. Pouchlý, J.: Fyzikální chemie makromolekulárních a koloidních soustav. Praha, Vydavatelství VŠCHT, 1998, 198 s.
  3. Hrazdira, I., Mornstein, V.: Úvod do obecné a lékařské biofyziky. Brno, Masarykova univerzita, Fakulta lékařská, 1998, 274 s.
  4. Flynn, G. L.: In: Modern Pharmaceutics (Banker, G. S., Rhodes, C. T., eds.), 2nd ed. Basel, New York, Marcel Dekker, 1990, s.263.
  5. Florence, A. T., Atwood, D.: Physicochemical principles of pharmacy. 3rd ed. London, Macmillan press Ltd., 1998, s.564. Go to original source...
  6. Friberg, S. E., Goldsmith-Quencer, L., Hilton, M. L. : In: Pharmaceutical Dosage Forms: Disperse Systems (Lieberman, H. A., Rieger, M. M., Banker, G. S. eds.), New York, Marcel Dekker, vol. 1, 1996, s. 53.
  7. Ranucci, J. A., Silverstein, I. B.: In Pharmaceutical dosage forms: Disperse systems (Lieberman, H. A., Rieger, M. M., Banker, G. S. eds.) New York, Marcel Dekker, vol. 3, 1998, s. 243.
  8. Táborská, E., Sláma, J.: Lékařská chemie I. Brno, Masarykova univerzita, Fakulta lékařská, 2001, 138 s.
  9. Vodrážka, Z.: Fyzikální chemie pro biologické vědy. 1. vyd. Praha, Academia, 1982, 565 s.
  10. Chalabala, M. et al.: Technologie léků. 2. vyd. Praha, Galén, 2001, s. 408.
  11. Buchman, S.: In: Handbook of Cosmetic Science and Technology (Barel, A. O., Paye, M., Maibach, H. I. eds.), New York, Marcel Dekker, 2001, s. 145.
  12. Jeong, B., Kim, S. W., Bae, Y. H.: Adv. Drug Deliv. Rev., 2002; 54, 37-51. Go to original source... Go to PubMed...
  13. Kavanagh, G. M., Ross-Murphy, S. B.: Prog. Polym. Sci., 1998; 23, 533-562. Go to original source...
  14. Klech, C. M.: In: Encyclopedia of Pharmaceutical Technology (Swarbrick, J., Boylan, J. C., eds.), New York, Marcel Dekker, vol. 6, 1992, s. 415.
  15. Pena, L. E.: In: Topical Drug Delivery Formulations (Osborne, D. W., Amann, A. H. eds.), New York, Basel, Marcel Dekker, 1990, s. 381.
  16. Schott, H.: In: Remington. The Science and Practice of Pharmacy (Gennaro, A. R. ed.), Easton Pennsylvania, Mack Publishing Company, 1995, s. 252.
  17. Český lékopis 2002, Praha, Grada Publishing a. s., 2001, 5756 s.
  18. Hatakeyama, H., Hatakeyama, T.: Thermochim. Acta, 1998; 308, 3-22. Go to original source...
  19. Chen, J., Jo, S., Park, K.: In: Handbook of Biodegradable polymers (Domb, A. J., Kost, J., Wiseman, D. M., eds.), Amsterdam, Harwood Academic Publishers, 1997, s. 526.
  20. Musset, J. H.: Pharmaceutical Practice. Edinburgh, Churchill Livingstone, 1998, s.176.
  21. Hoffman, A. S.: Adv. Drug Deliv. Rev., 2002; 54, 3-12. Go to original source... Go to PubMed...
  22. Qiu, Y., Park, K.: Adv. Drug Deliv. Rev., 2001; 53, 321-339. Go to original source... Go to PubMed...
  23. Peppas, N. A. et al.: Eur. J. Pharm. Biopharm. 2000; 50, 27-46. Go to original source... Go to PubMed...
  24. Nishinari, K., Zhang, H., Ikeda, S.: Curr. Opinion Colloid & Interface Sci., 2000; 5, 195-201. Go to original source...
  25. Drury, J. L., Mooney, D. J.: Biomaterials, 2003; 24, 4337-4351. Go to original source... Go to PubMed...
  26. Bouwstra, J. A., Junginger, H. E.: In: Encyclopedia of Pharmaceutical Technology, (Swarbrick, J., Boylan, J. C., eds.), New York, Marcel Dekker, 1993, s. 441.
  27. Braybrook, J. H.: In: Encyclopedia of Pharmaceutical Technology (Swarbrick, J., Boylan, J. C., eds.), New York, Marcel Dekker, 1995, vol. 12, s.265.
  28. Zatz, J. L., Kushla, G. P. : In: Pharmaceutical Dosage Forms: Disperse Systems (Lieberman, A., Rieger, M. M., Banker, G. S., eds.), 2nd ed., New York, Marcel Dekker, vol. 2, 1996, s. 399.
  29. Matsuda, T.: J. Controll. Release, 2002; 78, 125-131. Go to original source... Go to PubMed...
  30. Anseth, K. S. et. al.: J. Controll. Release, 2002; 78, 199-209. Go to original source... Go to PubMed...
  31. Nguyen, K. T., West, J. L.: Biomaterials, 2002; 23, 4307-4314. Go to original source... Go to PubMed...
  32. Miyata, T., Uragami, T., Nakamae, K.: Adv. Drug Deliv. Rev.,2002; 54, 79-98. Go to original source... Go to PubMed...
  33. Byrne, M. E., Park, K., Peppas, N. A.: Adv. Drug Deliv. Rev., 2002; 54, 149-161. Go to original source... Go to PubMed...
  34. Soppimath, K. S. et al.: Drug Devel. Ind. Pharm., 2002; 28, 957-974. Go to original source... Go to PubMed...
  35. Takahashi, A. et al.: Int. J. Pharm., 2002; 246, 179-186. Go to original source... Go to PubMed...
  36. Pandit, N. K., McGowan, R.: Drug Devel. Ind. Pharm., 1998; 24, 183-186. Go to original source... Go to PubMed...
  37. Ishihara, M. et al.: Biomaterials, 2002; 23, 833-840. Go to original source... Go to PubMed...
  38. Bandelin, F.,J., Sheth, B. B.: In: Encyclopedia of Pharmaceutical Technology, (Swarbrick, J., Boylan, J. C., eds.), New York, Marcel Dekker, 1996, vol. 14, s. 31.
  39. The Pharmaceutical Codex (Lund, W. ed.) 12th ed. London, The Pharmaceutical Press, 1994, 1117 s.
  40. Vitkova, Z., Gardavska, K., Cizmarik, J.: Pharmazie, 1995; 50, 199-200. Go to original source...
  41. Gardavská, k., Vitkova, Z., Cizmarik, J.: Pharmazie, 2003; 58, 156-157.
  42. Feldstein, M. M. et al.: In Proc. 2nd World Meeting APGI/APV, Paris, 25/28 May, 1998, 821-822.
  43. Draye, J. P. et al: In Proc. 2 nd World Meeting APGI/APV, Paris, 25/28 May 1998, 813-814. Go to original source...
  44. Kikuchi, A., Okano, T.: Adv. Drug Deliv. Rev., 2002; 54, 53-57. Go to original source... Go to PubMed...
  45. Needleman, I. G., Smales, F. C., Martin, G. P.: J. Clin. Periodontol. 1997; 24, 394-400. Go to original source... Go to PubMed...
  46. Dostálová, M., Rabišková, M.: Čes. slov. Farm., 2000; 49, 55-61.
  47. Zatz, J. L., Berry, J. J., Alderman, D. A.: In: Pharmaceutical Dosage Forms (Lieberman, H. A., Rieger, M. M., Banker, G. S. eds.) New York, Marcel Dekker, 1996, vol. 1, s. 287.
  48. Nairn, J. G. : In: Encyclopedia of Pharmaceutical Technology (Swarbrick, J., Boylan, J. C., eds.), New York, Marcel Dekker, vol. 15, 1997, s. 213.
  49. Chalabala, M., Ducková, K.: Slovakofarma revue, 1995; V, 2, 46-47.
  50. Novotný, F. et al.: Obecná dermatologie. 1. vyd. Praha, Avicenum, 1989, s. 311.
  51. Behl, C. R. et al.: Adv. Drug Deliv. Rev., 1998; 29, 89-116. Go to original source... Go to PubMed...
  52. Kublik, H., Vidgren, M. T.: Adv. Drug Deliv. Rev., 1998; 29, 157-177. Go to original source... Go to PubMed...
  53. Nakamura, K., Maitani, Y.: J. Controll. Release, 1999; 61, 329-335. Go to original source... Go to PubMed...
  54. Li, J., Xu, Z.: J. Pharm. Sci., 2002; 91, 1669-1677. Go to original source... Go to PubMed...
  55. Masteiková, R., Chalupová, Z., Šklubalová, Z.: Medicina, 2003, 39, 19-24. Go to original source...
  56. Zignani, M., et al.: Adv. Drug Deliv. Rev., 1995; 16, 51-60. Go to original source...
  57. Gurny, R., Ibrahim, H., Buri, P.: In Biopharmaceutics of Ocular Drug Delivery (Edman, P. ed), Boca Raton, CRC Press, 1993, s. 202.
  58. Lin, H. R., Sung, K. C.: J. Controll. Release, 2000; 69, 379-388. Go to original source... Go to PubMed...
  59. Srividya, B., Cardoza, R. M., Amin, P. D.: J. Controll. Release., 2001; 73, 205-211. Go to original source... Go to PubMed...
  60. Wei, G., et al.: J. Controll. Release, 2002; 83, 65-74. Go to original source... Go to PubMed...
  61. Rozier, A.: Int. J. Pharm., 1989; 57, 163-168. Go to original source...
  62. Paulsson, M., Hagerstrom, H., Edsman K.: Eur. J. Pharm. Sci., 1999; 9, 99-105. Go to original source... Go to PubMed...
  63. Chenite, A., et al.: Biomaterials, 2000; 21, 2155-2161. Go to original source... Go to PubMed...
  64. Hatefi, A., Amsden, B.: J. Controll. Release, 2002; 80, 9-28. Go to original source... Go to PubMed...
  65. Paavola, A., et al.: J. Controll. Release, 1998; 52, 169-178. Go to original source... Go to PubMed...
  66. Choi, H. G., et al.: Int. J. Pharm., 1998; 165, 23-32. Go to original source...
  67. Ryu, J. M. et al.: J. Controll. Release, 1999; 59, 163-172. Go to original source... Go to PubMed...
  68. Choi, H. G., et al.: Int. J. Pharm.., 1998; 165, 33-44. Go to original source...
  69. Miyazaki, S., et al.: J. Controll. Release, 1998; 56, 75-83. Go to original source... Go to PubMed...
  70. Vermani, K., Garg, S.: Farm. Sci. & Technol. Today, 2000; 3, 359-364. Go to original source... Go to PubMed...
  71. Chang, J. Y. et al.: J. Controll. Release, 2002; 82, 39-50. Go to original source... Go to PubMed...
  72. Weidner, J.: Drug Discovery Today, 2002; 7, 1230-1231. Go to original source...
  73. Kubo, W., Miyazaki, S., Attwood, D.: Int. J. Pharm.,2003; 258, 55-64. Go to original source... Go to PubMed...
  74. Bühler, V.: Kollidon. 3nd ed. Ludwigshafen, BASF, 1996, s. 287.
  75. Sinha, V. R., Khosla, L.: Drug Devel. Ind. Pharm., 1998; 24, 1129-1138. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.